The Claim
In glucose-deprived conditions, the GLUT5 transporter physically interacts with ketohexokinase (KHK) to prevent its degradation via autophagy, thereby increasing fructose flux into energy-producing metabolic pathways in colorectal cancer cells.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When glucose is unavailable, the GLUT5 transporter binds to ketohexokinase in colorectal cancer cells to stop its breakdown by autophagy, which increases the use of fructose for energy production.
See the scientific wording
In glucose-deprived conditions, the GLUT5 transporter physically interacts with ketohexokinase (KHK) to prevent its degradation via autophagy, thereby increasing fructose flux into energy-producing metabolic pathways in colorectal cancer cells.
When glucose is scarce, cells import fructose using GLUT5, which binds to ketohexokinase and stops it from being broken down. This allows fructose to be converted into energy and building blocks for cell growth, helping cancer cells survive and resist treatment.
What the research says
1 studyWhen sugar (glucose) is low, colorectal cancer cells use another sugar (fructose) for energy. To do this, they link two proteins—GLUT5 and KHK—to stop KHK from being destroyed, which lets them turn fructose into energy more efficiently.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.